US Patent Issued to Hoffmann-La Roche on Dec. 23 for "Triazatricycle compounds for the treatment of autoimmune disease" (Chinese, Swiss Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,503,471, issued on Dec. 23, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.).

"Triazatricycle compounds for the treatment of autoimmune disease" was invented by Fabian Dey (Zurich), Hong Shen (Shanghai), Hongtao Xu (Shanghai), Wei Zhu (Shanghai) and Ge Zou (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds of formula (I), wherein R1 to R3 and n are as described herein, and their pharmaceutically acceptable salt thereof, and compositions including the compounds and methods of using the compounds."

The patent was filed on Nov. 17, 2020, under Application No. 17/777,588.

*For further information...